102 related articles for article (PubMed ID: 18441571)
1. [Cell transplantation study with German patients. Can retinal cells save the Parkinson brain?].
Sturm V
MMW Fortschr Med; 2004 Jan; 146(1-2):9. PubMed ID: 18441571
[No Abstract] [Full Text] [Related]
2. Retinal pigment epithelial cells: biological property and application in Parkinson's disease.
Ming M; LE WD
Chin Med J (Engl); 2007 Mar; 120(5):416-20. PubMed ID: 17376314
[No Abstract] [Full Text] [Related]
3. [New approaches to transplantation of dopamine-producing cells and stem cells].
Reichmann H; Gossrau G; Sommer U
Nervenarzt; 2003 Mar; 74 Suppl 1():S22-6. PubMed ID: 12624680
[No Abstract] [Full Text] [Related]
4. Characterization and survival of long-term implants of human retinal pigment epithelial cells attached to gelatin microcarriers in a model of Parkinson disease.
Flores J; Cepeda IL; Cornfeldt ML; O'Kusky JR; Doudet DJ
J Neuropathol Exp Neurol; 2007 Jul; 66(7):585-96. PubMed ID: 17620984
[TBL] [Abstract][Full Text] [Related]
5. Intrastriatal implantation of human retinal pigment epithelial cells attached to microcarriers in advanced Parkinson disease.
Stover NP; Bakay RA; Subramanian T; Raiser CD; Cornfeldt ML; Schweikert AW; Allen RC; Watts RL
Arch Neurol; 2005 Dec; 62(12):1833-7. PubMed ID: 16344341
[TBL] [Abstract][Full Text] [Related]
6. Human retinal pigment epithelial cell implants ameliorate motor deficits in two rat models of Parkinson disease.
Cepeda IL; Flores J; Cornfeldt ML; O'Kusky JR; Doudet DJ
J Neuropathol Exp Neurol; 2007 Jul; 66(7):576-84. PubMed ID: 17620983
[TBL] [Abstract][Full Text] [Related]
7. Pathologic findings in retinal pigment epithelial cell implantation for Parkinson disease.
Farag ES; Vinters HV; Bronstein J
Neurology; 2009 Oct; 73(14):1095-102. PubMed ID: 19726750
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of computer-assisted stereotactic transplantation of human retinal pigment epithelium cells in the treatment of Parkinson disease.
Xue Y; Li X; Pang S; Wang Y; Yao J; Zhou J; Hao P
J Comput Assist Tomogr; 2013; 37(3):333-7. PubMed ID: 23674001
[TBL] [Abstract][Full Text] [Related]
9. Cell-based therapies to limit photoreceptor degeneration.
Lund R
Arch Soc Esp Oftalmol; 2008 Aug; 83(8):457-64. PubMed ID: 18661440
[No Abstract] [Full Text] [Related]
10. The fourth dimension of stereotaxis: timing of neurosurgery for Parkinson disease.
Riley D; Lozano A
Neurology; 2007 Jan; 68(4):252-3. PubMed ID: 17242330
[No Abstract] [Full Text] [Related]
11. Improvement in Parkinson disease by subthalamic nucleus stimulation based on electrode placement: effects of reimplantation.
Anheim M; Batir A; Fraix V; Silem M; Chabardès S; Seigneuret E; Krack P; Benabid AL; Pollak P
Arch Neurol; 2008 May; 65(5):612-6. PubMed ID: 18474736
[TBL] [Abstract][Full Text] [Related]
12. Transplantation of tissue-engineered retinal pigment epithelial cell sheets in a rabbit model.
Yaji N; Yamato M; Yang J; Okano T; Hori S
Biomaterials; 2009 Feb; 30(5):797-803. PubMed ID: 19036433
[TBL] [Abstract][Full Text] [Related]
13. What is the risk of sham surgery in Parkinson disease clinical trials? A review of published reports.
Landau W
Neurology; 2006 Jun; 66(11):1788-9; author reply 1788-9. PubMed ID: 16769977
[No Abstract] [Full Text] [Related]
14. Long-term superiority of subthalamic nucleus stimulation over pallidotomy in Parkinson disease.
Esselink RA; de Bie RM; de Haan RJ; Lenders MW; Nijssen PC; van Laar T; Schuurman PR; Bosch DA; Speelman JD
Neurology; 2009 Jul; 73(2):151-3. PubMed ID: 19597136
[No Abstract] [Full Text] [Related]
15. Vision improvement in retinal degeneration patients by implantation of retina together with retinal pigment epithelium.
Radtke ND; Aramant RB; Petry HM; Green PT; Pidwell DJ; Seiler MJ
Am J Ophthalmol; 2008 Aug; 146(2):172-182. PubMed ID: 18547537
[TBL] [Abstract][Full Text] [Related]
16. Studying neurosurgical implants for Parkinson disease: a question of design.
Prehn AW; Vawter DE; Gervais KG; DeVries RG; Garrett JE; Freeman TB; McIndoo TQ
Neurology; 2006 Oct; 67(8):1503-5. PubMed ID: 17060588
[TBL] [Abstract][Full Text] [Related]
17. Deep brain stimulation--surgery for movement disorders and Parkinson's disease.
Frost EA; Osborn I
Int Anesthesiol Clin; 2009; 47(2):57-68. PubMed ID: 19359876
[No Abstract] [Full Text] [Related]
18. Stereotaxic intrastriatal implantation of human retinal pigment epithelial (hRPE) cells attached to gelatin microcarriers: a potential new cell therapy for Parkinson's disease.
Watts RL; Raiser CD; Stover NP; Cornfeldt ML; Schweikert AW; Allen RC; Subramanian T; Doudet D; Honey CR; Bakay RA
J Neural Transm Suppl; 2003; (65):215-27. PubMed ID: 12946059
[TBL] [Abstract][Full Text] [Related]
19. Prospects for Parkinson disease.
Nat Med; 2001 Apr; 7(4):381. PubMed ID: 11283634
[No Abstract] [Full Text] [Related]
20. Deep brain stimulation in Parkinson's disease following fetal nigral transplantation.
Herzog J; Pogarell O; Pinsker MO; Kupsch A; Oertel WH; Lindvall O; Deuschl G; Volkmann J
Mov Disord; 2008 Jul; 23(9):1293-6. PubMed ID: 18536037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
